These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 7998114
1. Review of CTLA4Ig use for allograft immunosuppression. Lin H, Wei RQ, Gordon D, Linsley P, Turka LA, Bolling SF. Transplant Proc; 1994 Dec; 26(6):3200-1. PubMed ID: 7998114 [No Abstract] [Full Text] [Related]
2. Immunomodulation with intrathymic injection of donor splenocytes followed by CTLA4Ig therapy prolongs small intestinal allograft survival. Greenstein SM, Sun S, Schechner RS, Tellis VA. Transplant Proc; 1997 Dec; 29(1-2):1065-6. PubMed ID: 9123201 [No Abstract] [Full Text] [Related]
3. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. Lin H, Bolling SF, Linsley PS, Wei RQ, Gordon D, Thompson CB, Turka LA. J Exp Med; 1993 Nov 01; 178(5):1801-6. PubMed ID: 8228826 [Abstract] [Full Text] [Related]
4. Prolonged rat cardiac allograft survival using adenoviral vector containing the CTLA4Ig gene. Kita Y, Li XK, Hayashi S, Funeshima N, Enosawa S, Tamura A, Suzuki K, Kazui T, Amemiya H, Suzuki S. Transplant Proc; 1998 Jun 01; 30(4):1079-80. PubMed ID: 9636437 [No Abstract] [Full Text] [Related]
5. Prolonged allograft survival but no tolerance induction by modulating CD28 antibody JJ319 after high-responder rat heart transplantation. Dengler TJ, Szabo G, Sido B, Nottmeyer W, Zimmerman R, Vahl CF, Hünig T, Meuer SC. Transplantation; 1999 Feb 15; 67(3):392-8. PubMed ID: 10030284 [Abstract] [Full Text] [Related]
6. Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing. Bolling SF, Lin H, Wei RQ, Turka LA. J Heart Lung Transplant; 1996 Sep 15; 15(9):928-35. PubMed ID: 8889989 [Abstract] [Full Text] [Related]
7. CD28-pathway blockade with CTLA4Ig leads to prolongation of small bowel transplant survival in rats. Pescovitz MD, Yang R, Liu Q, Collins MH, Grosfeld JL. Transplant Proc; 1994 Jun 15; 26(3):1618-9. PubMed ID: 8030059 [No Abstract] [Full Text] [Related]
8. Prolongation of rat to mouse skin and heart xenograft survival by combined CTLA4Ig and anti-CD4/CD8 antibody. Tu Y, Rehman A, Flye MW. Transplant Proc; 1996 Aug 15; 28(4):2061-2. PubMed ID: 8769156 [No Abstract] [Full Text] [Related]
9. Combined CTLA4Ig and anti-CD4/DC8 monoclonal antibody treatment prolongs survival of rat-to-mouse heterotopic cardiac xenografts. Rehman A, Tu Y, Flye MW. Transplant Proc; 1996 Apr 15; 28(2):660-1. PubMed ID: 8623331 [No Abstract] [Full Text] [Related]
10. Reversal of CTLA4Ig-mediated tolerance to cardiac allografts by exogenous interleukin-2. Arima T, Rehman A, Flye MW. Transplant Proc; 1997 Apr 15; 29(1-2):1305-6. PubMed ID: 9123318 [No Abstract] [Full Text] [Related]
11. CD28 blockade alters cytokine mRNA profiles in cardiac transplantation. Lin H, Wei RQ, Goodman RE, Bolling SF. Surgery; 1997 Aug 15; 122(2):129-37. PubMed ID: 9288115 [Abstract] [Full Text] [Related]
12. Soluble CTLA4Ig modifies acute rejection of rat lung allografts without blocking accumulation of key cytokine transcripts. Matsumura Y, Zuo XJ, Prehn J, Linsley P, Marchevsky A, Kass R, Matloff J, Jordan SC. Transplant Proc; 1995 Feb 15; 27(1):406-8. PubMed ID: 7879040 [No Abstract] [Full Text] [Related]
13. Perioperative administration of FTY720 and CTLA4IG in rat heart transplantation. Ohba M, Li XK, Kita Y, Tamura A, Enosawa S, Sasakuri S, Ogoshi S, Amemiya H, Suzuki S. Transplant Proc; 2000 Nov 15; 32(7):2024-5. PubMed ID: 11120049 [No Abstract] [Full Text] [Related]
14. CTLA4Ig inhibits alloantibody responses to transfusions and transplants. Ibrahim S, Jakobs F, Linsley PS, Sanfilippo F, Baldwin WM. Transplant Proc; 1997 Nov 15; 29(1-2):1025. PubMed ID: 9123179 [No Abstract] [Full Text] [Related]
15. Effect of simultaneous intrathymic injection of two unrelated cellular alloantigens on rat cardiac allograft survival. Shimomura K, Hardy MA, Oluwole SF. Transplant Proc; 1995 Feb 15; 27(1):127. PubMed ID: 7878878 [No Abstract] [Full Text] [Related]
16. Adenovirus-mediated gene transfer of CTLA4IG gene results in prolonged survival of heart allograft. Guang-Lin M, Hayashi S, Yokoyama I, Namii Y, Kobayashi T, Katayama A, Nagasaka T, Hamada H, Negita M, Takagi H. Transplant Proc; 1998 Nov 15; 30(7):2923-4. PubMed ID: 9838288 [No Abstract] [Full Text] [Related]
17. Distinct tolerance pathways in sensitized rat recipients after blockade of activation signal 1 and signal 2. Onodera K, Chandraker A, Kato H, Volk HD, Sayegh MH, Kupiec-Weglinski JW. Transplant Proc; 1999 Nov 15; 31(1-2):876-7. PubMed ID: 10083384 [No Abstract] [Full Text] [Related]
18. Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2. Onodera K, Chandraker A, Volk HD, Ritter T, Lehmann M, Kato H, Sayegh MH, Kupiec-Weglinski JW. Transplantation; 1999 Jul 27; 68(2):288-93. PubMed ID: 10440403 [Abstract] [Full Text] [Related]
19. CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses. Onodera K, Chandraker A, Schaub M, Stadlbauer TH, Korom S, Peach R, Linsley PS, Sayegh MH, Kupiec-Weglinski JW. J Immunol; 1997 Aug 15; 159(4):1711-7. PubMed ID: 9257832 [Abstract] [Full Text] [Related]
20. CD4-targeted therapy and CD28-B7 costimulatory blockage may independently induce tolerance in sensitized allograft recipients. Kato H, Onodera K, Chandraker A, Volk HD, Sayegh MH, Kupiec-Weglinski JW. Transplant Proc; 1998 Jun 15; 30(4):1063-4. PubMed ID: 9636430 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]